Valuation: ConvaTec Group

Market Cap 5.59B 4.88B 4.61B 4.18B 7.84B 537B 7.87B 55.17B 21.29B 273B 21.01B 20.55B 878B P/E 2026 *
22.2x
P/E 2027 * 15.2x
Enterprise Value 7B 6.1B 5.76B 5.23B 9.8B 671B 9.84B 69B 26.63B 341B 26.28B 25.7B 1,098B EV / Sales 2026 *
2.74x
EV / Sales 2027 * 2.49x
Free-Float
95.12%
Yield 2026 *
2.78%
Yield 2027 * 3.18%
Manager TitleAgeSince
Chief Executive Officer 62 2025-08-03
Director of Finance/CFO 51 2025-08-03
Chief Operating Officer - 2026-05-31
Director TitleAgeSince
Director/Board Member 71 2017-08-13
Chairman 78 2019-09-29
Director/Board Member 62 2020-03-01
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 5.59B
+0.37%+0.65%-23.75%+1.59% 178B
-0.69%+1.29%-3.62%+11.27% 118B
-0.20%-3.98%+6.17%+72.47% 58.92B
-0.24%+1.74%-3.94%-31.61% 49.29B
-0.22%-0.37%+7.26%+35.20% 48.17B
+1.61%+7.61%+17.91%-6.24% 33.72B
-1.49%-2.74% - - 27.76B
-1.17%+4.64%+42.09%-8.18% 25.5B
+1.02%+5.99%+7.20%-19.54% 22.1B
Average -0.10%+1.85%+6.16%+6.87% 62.32B
Weighted average by Cap. -0.08%+1.03%-4.29%+9.69%

Financials

2026 *2027 *
Net sales 2.55B 2.23B 2.1B 1.91B 3.58B 245B 3.59B 25.2B 9.72B 125B 9.6B 9.38B 401B 2.73B 2.38B 2.25B 2.04B 3.83B 262B 3.84B 26.96B 10.4B 133B 10.27B 10.04B 429B
Net income 250M 218M 206M 187M 350M 23.98B 351M 2.46B 951M 12.19B 939M 918M 39.22B 365M 318M 301M 273M 511M 35.02B 513M 3.6B 1.39B 17.81B 1.37B 1.34B 57.29B
Net Debt 1.4B 1.22B 1.15B 1.05B 1.96B 135B 1.97B 13.83B 5.34B 68.42B 5.27B 5.15B 220B 1.22B 1.07B 1.01B 915M 1.71B 117B 1.72B 12.07B 4.66B 59.7B 4.6B 4.49B 192B
Logo ConvaTec Group
ConvaTec Group Plc specializes in the development, manufacturing and marketing of medical devices and products for ostomy care, wound care, and incontinence. The group also offers perfusion devices. Net sales break down by area of activity as follows: - wound care (30.9%): antimicrobial dressings, occlusive dressings, compression bandages, etc.; - ostomy care (27.7%): skin barriers, one-piece bags, 2-piece appliance bags, urostomy bags, etc.; - incontinence care (22%); - infusion (19.4%). At the end of 2025, the group operated 7 production sites worldwide. Net sales are distributed geographically as follows: Europe (29.6%), North Americas (55.7%) and other (14.7%).
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
AAA
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!